Urinary metals and heart rate variability: A cross-sectional study of urban adults in Wuhan, China

Environmental Health Perspectives

Volumn 123, Issue 3, 2015, Pages 217-222

  Feng, Wei ^a,b   He, Xiaosheng ^a,b   Chen, Mu ^a,b,c   Deng, Siyun ^a,b   Qiu, Gaokun ^a,b   Li, Xiaoliang ^a,b   Liu, Chuanyao ^a,b   Li, Jun ^a,b   Deng, Qifei ^a,b   Huang, Suli ^a,b   Wang, Tian ^a,b   Dai, Xiayun ^a,b   Yang, Binyao ^a,b   Yuan, Jing ^a,b   He, Meian ^a,b   Zhang, Xiaomin ^a,b   Chen, Weihong ^a,b   Kan, Haidong ^d   Wu, Tangchun ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; ANTIMONY; ARSENIC; BARIUM; CADMIUM; CHROMIUM; COBALT; COPPER; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IRON; LEAD; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MANGANESE; MOLYBDENUM; NICKEL; RUBIDIUM; SELENIUM; STRONTIUM; THALLIUM; TIN; TITANIUM; TRIACYLGLYCEROL; TUNGSTEN; URANIUM; VANADIUM; ZINC; METAL; POLLUTANT;

ADULT; AGED; ARTICLE; CHINA; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; FRAMINGHAM RISK SCORE; HEART RATE VARIABILITY; HEAVY METAL POISONING; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; LIFE EXPECTANCY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE; URINE LEVEL; ADOLESCENT; ADVERSE EFFECTS; ANALYSIS; BODY MASS; CARDIOVASCULAR DISEASES; ELECTROCARDIOGRAPHY; HEART RATE; MIDDLE AGED; PHYSIOLOGY; POLLUTANT; RISK FACTOR; SMOKING; STATISTICS AND NUMERICAL DATA; URBAN POPULATION; URINE; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHINA; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY, AMBULATORY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; METALS; MIDDLE AGED; RISK FACTORS; SMOKING; URBAN POPULATION;

EID: 84925105790     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1307563     Document Type: Article

References (46)

1. Ahmed M, Fatmi Z, Ali A. 2014. Correlation of arsenic exposure through drinking groundwater and urinary arsenic excretion among adults in Pakistan. J Environ Health 76:48–54.
2. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. 2005. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 113:192–200; doi:10.1289/ehp.7337.
3. Berry WL, Stimmann MW, Wolf WW. 1972. Marking of native phytophagous insects with rubidium: a proposed technique. Ann Entomol Soc Am 65:236–238.
4. Cantoni E, Ronchetti E. 2001. Robust inference for generalized linear models. J Am Stat Assoc 96:1022–1030.
5. Cavallari JM, Eisen EA, Fang SC, Schwartz J, Hauser R, Herrick RF, et al. 2008. PM2.5 metal exposures and nocturnal heart rate variability: a panel study of boilermaker construction workers. Environ Health 7:36; doi:10.1186/1476-069X-7-36.
6. Chiba M, Masironi R. 1992. Toxic and trace elements in tobacco and tobacco smoke. Bull World Health Organ 70:269–275.
7. Coogan TP, Latta DM, Snow ET, Costa M. 1989. Toxicity and carcinogenicity of nickel compounds. Crit Rev Toxicol 19:341–384.
8. de Hartog JJ, Lanki T, Timonen KL, Hoek G, Janssen NA, Ibald-Mulli A, et al. 2009. Associations between PM2.5 and heart rate varia bility are modifed by particle composition and beta-blocker use in patients with coronary heart disease. Environ Health Perspect 117:105–111; doi:10.1289/ehp.11062.
9. Feng Y, Sun H, Song Y, Bao J, Huang X, Ye J, et al. 2014. A community study of the effect of polycyclic aromatic hydrocarbon metabolites on heart rate variability based on the Framingham risk score. Occup Environ Med 71:338–345.
10. Gallieni M, Brancaccio D, Cozzolino M, Sabbioni E. 1996. Trace elements in renal failure: are they clinically important? Nephrol Dial Transplant 11:1232–1235.
11. Goldstein DS, Bentho O, Park MY, Sharabi Y. 2011. Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may be a measure of modulation of cardiac autonomic outfows by barorefexes. Exp Physiol 96:1255–1261.
12. Hearse DJ. 1991. Reperfusion-induced injury: a possible role for oxidant stress and its manipulation. Cardiovasc Drugs Ther 5(suppl 2):225–235.
13. Heitland P, Köster HD. 2006. Biomonitoring of 30 trace elements in urine of children and adults by ICP-MS. Clin Chim Acta 365:310–318.
14. IARC (International Agency for Research on Cancer). 2010. Carbon black, titanium dioxide, and talc. IARC Monogr Eval Carcinog Risks Hum 93:1–413.
15. Jhun HJ, Kim H, Paek DM. 2005. The association between blood metal concentrations and heart rate variability: a cross-sectional study. Int Arch Occup Environ Health 78:243–247.
16. Jomova K, Valko M. 2011. Advances in metal-induced oxidative stress and human disease. Toxicology 283:65–87.
17. Kim H, Lee HJ, Hwang JY, Ha EH, Park H, Ha M, et al. 2010. Blood cadmium concentrations of male cigarette smokers are inversely associated with fruit consumption. J Nutr 140:1133–1138.
18. Li X, Feng Y, Deng H, Zhang W, Kuang D, Deng Q, et al. 2012. The dose-response decrease in heart rate variability: any association with the metabolites of polycyclic aromatic hydrocarbons in coke oven workers? PloS One 7:e44562; doi:10.1371/journal.pone.0044562.
19. Linsinger T. 2005. Comparison of Measurement Result with the Certifed Value. ERM Application Note 1. Available: http://www.erm-crm.org/ERM_products/application_notes/application_note_1/ Documents/erm_application_note_1_english_ rev3.pdf [accessed 6 February 2015].
20. Magari SR, Schwartz J, Williams PL, Hauser R, Smith TJ, Christiani DC. 2002. The association of particulate air metal concentrations with heart rate variability. Environ Health Perspect 110:875–880.
21. Malik M, Bigger JT, Camm AJ, Kleiger RE, Malliani A, Moss AJ, et al. 1996. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 17:354–381.
22. Mendy A, Gasana J, Vieira ER. 2012. Urinary heavy metals and associated medical conditions in the US adult population. Int J Environ Health Res 22:105–118.
23. Mordukhovich I, Wright RO, Hu H, Amarasiriwardena C, Baccarelli A, Litonjua A, et al. 2012. Associations of toenail arsenic, cadmium, mercury, manganese, and lead with blood pressure in the Normative Aging Study. Environ Health Perspect 120:98–104; doi:10.1289/ehp.1002805.
24. Mortensen ME, Wong LY, Osterloh JD. 2011. Smoking status and urine cadmium above levels associated with subclinical renal effects in U.S. adults without chronic kidney disease. Int J Hyg Environ Health 214:305–310.
25. Mumford JL, Wu K, Xia Y, Kwok R, Yang Z, Foster J, et al. 2007. Chronic arsenic exposure and cardiac repolarization abnormalities with QT interval prolongation in a population-based study. Environ Health Perspect 115:690–694; doi:10.1289/ehp.9686.
26. Navas-Acien A, Guallar E, Silbergeld EK, Rothenberg SJ. 2007. Lead exposure and cardiovascular disease—a systematic review. Environ Health Perspect 115:472–482; doi:10.1289/ehp.9785.
27. Navas-Acien A, Selvin E, Sharrett AR, Calderon-Aranda E, Silbergeld E, Guallar E. 2004. Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation 109:3196–3201.
28. Navas-Acien A, Sharrett AR, Silbergeld EK, Schwartz BS, Nachman KE, Burke TA, et al. 2005. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol 162:1037–1049.
29. Niemelä MJ, Airaksinen KE, Huikuri HV. 1994. Effect of beta-blockade on heart rate variability in patients with coronary artery disease. J Am Coll Cardiol 23:1370–1377.
30. Park SK, Schwartz J, Weisskopf M, Sparrow D, Vokonas PS, Wright RO, et al. 2006. Low-level lead exposure, metabolic syndrome, and heart rate variability: the VA Normative Aging Study. Environ Health Perspect 114:1718–1724; doi:10.1289/ehp.8992.
31. Pike N. 2011. Using false discovery rates for multiple comparisons in ecology and evolution. Methods Ecol Evol 2:278–282.
32. Qu CS, Ma ZW, Yang J, Liu Y, Bi J, Huang L. 2012. Human exposure pathways of heavy metals in a lead-zinc mining area, Jiangsu Province, China. PloS One 7:e46793; doi:10.1371/journal.pone.0046793.
33. Quandt SA, Jones BT, Talton JW, Whalley LE, Galván L, Vallejos QM, et al. 2010. Heavy metals exposures among Mexican farmworkers in eastern North Carolina. Environ Res 110:83–88.
34. Rhoden CR, Wellenius GA, Ghelfi E, Lawrence J, González-Flecha B. 2005. PM-induced cardiac oxidative stress and dysfunction are mediated by autonomic stimulation. Biochim Biophys Acta 1725:305–313.
35. Schisterman EF, Whitcomb BW, Louis GM, Louis TA. 2005. Lipid adjustment in the analysis of environmental contaminants and human health risks. Environ Health Perspect 113:853–857; doi:10.1289/ehp.7640.
36. Smith AH, Hopenhayn-Rich C, Bates MN, Goeden HM, Hertz-Picciotto I, Duggan HM, et al. 1992. Cancer risks from arsenic in drinking water. Environ Health Perspect 97:259–267.
37. Song Y, Hou J, Huang X, Zhang X, Tan A, Rong Y, et al. 2014. The Wuhan-Zhuhai (WHZH) cohort study of environmental air particulate matter and the pathogenesis of cardiopulmonary diseases: study design, methods and baseline characteristics of the cohort. BMC Public Health 14:994; doi: 10.1186/1471-2458-14-994.
38. Sun Z, Tao Y, Li S, Ferguson KK, Meeker JD, Park SK, et al. 2013. Statistical strategies for constructing health risk models with multiple pollutants and their interactions: possible choices and comparisons. Environ Health 12:85; doi: 10.1186/1476-069X-12-85.
39. Tellez-Plaza M, Guallar E, Howard BV, Umans JG, Francesconi KA, Goessler W, et al. 2013. Cadmium exposure and incident cardiovascular disease. Epidemiology 24:421–429.
40. Tellez-Plaza M, Navas-Acien A, Menke A, Crainiceanu CM, Pastor-Barriuso R, Guallar E. 2012. Cadmium exposure and all-cause and cardiovascular mortality in the U.S. general population. Environ Health Perspect 120:1017–1022; doi:10.1289/ehp.1104352.
41. Tolbert PE, Klein M, Peel JL, Sarnat SE, Sarnat JA. 2007. Multipollutant modeling issues in a study of ambient air quality and emergency department visits in Atlanta. J Expo Sci Environ Epidemiol 17(suppl 2):S29–S35.
42. Waisberg M, Joseph P, Hale B, Beyersmann D. 2003. Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology 192:95–117.
43. Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. 1998. Prediction of coronary heart disease using risk factor categories. Circulation 97:1837–1847.
44. Wu CF, Li YR, Kuo IC, Hsu SC, Lin LY, Su TC. 2012. Investigating the association of cardiovascular effects with personal exposure to particle components and sources. Sci Total Environ 431:176–182.
45. Wu S, Deng F, Niu J, Huang Q, Liu Y, Guo X. 2011. Exposures to PM2.5 components and heart rate variability in taxi drivers around the Beijing 2008 Olympic Games. Sci Total Environ 409:2478–2485.
46. Zeger SL, Thomas D, Dominici F, Samet JM, Schwartz J, Dockery D, et al. 2000. Exposure measurement error in time-series studies of air pollution: concepts and consequences. Environ Health Perspect 108:419–426.